Show simple item record

dc.contributor.authorJoshi, Anand Anant
dc.contributor.authorMurray, Thomas F.
dc.contributor.authorAldrich, Jane V.
dc.date.accessioned2017-04-18T18:02:22Z
dc.date.available2017-04-18T18:02:22Z
dc.date.issued2015-11-25
dc.identifier.citationJoshi, A. A., Murray, T. F., & Aldrich, J. V. (2015). Structure-Activity Relationships of the Peptide Kappa Opioid Receptor Antagonist Zyklophin. Journal of Medicinal Chemistry, 58(22), 8783–8795. http://doi.org/10.1021/jm501827ken_US
dc.identifier.urihttp://hdl.handle.net/1808/23730
dc.description.abstractThe dynorphin (Dyn) A analog zyklophin ([N-benzyl-Tyr1-cyclo(D-Asp5,Dap8)]dynorphin A(1-11)NH2) is a kappa opioid receptor (KOR) selective antagonist in vitro, is active in vivo and antagonizes KOR in the CNS after systemic administration. Hence, we synthesized zyklophin analogs to explore the structure-activity relationships of this peptide. The synthesis of selected analogs required modification to introduce the N-terminal amino acid due to poor solubility and/or to avoid epimerization of this residue. Among the N-terminal modifications the N-phenethyl and the N-cyclopropylmethyl substitutions resulted in the analogs with the highest KOR affinities. Pharmacological results for the alanine-substituted analogs indicated that Phe4 and Arg6, but interestingly not the Tyr1, phenol are important for zyklophin’s KOR affinity, and Arg7 was important for KOR antagonist activity. In the GTPγS assay while all of the cyclic analogs exhibited negligible KOR efficacy, the N-phenethyl-Tyr1, N-CPM-Tyr1 and the N-benzyl-Phe1 analogs were 8- to 24-fold more potent KOR antagonists than zyklophin.en_US
dc.publisherAmerican Chemical Societyen_US
dc.rightsPer SHERPA/RoMEO 4/18/2017: Author's Pre-print: grey tick subject to Restrictions below, author can archive pre-print (ie pre-refereeing) Restrictions:

Must obtain written permission from Editor Must not violate ACS ethical Guidelines

Author's Post-print: grey tick subject to Restrictions below, author can archive post-print (ie final draft post-refereeing) Restrictions:

If mandated by funding agency or employer/ institution If mandated to deposit before 12 months, must obtain waiver from Institution/Funding agency or use AuthorChoice 12 months embargo

Publisher's Version/PDF: cross author cannot archive publisher's version/PDF General Conditions:

On author's personal website, pre-print servers, institutional website, institutional repositories or subject repositories Non-Commercial Must be accompanied by set statement (see policy) Must link to publisher version Publisher's version/PDF cannot be used
en_US
dc.titleStructure-Activity Relationships of the Peptide Kappa Opioid Receptor Antagonist Zyklophinen_US
dc.typeArticleen_US
kusw.kuauthorJoshi, Anand A.
kusw.kuauthorAldrich, Jane V.
kusw.kudepartmentMedicinal Chemistryen_US
dc.identifier.doi10.1021/jm501827ken_US
dc.identifier.orcidhttps://orcid.org/0000-0003-4940-7998
kusw.oaversionScholarly/refereed, author accepted manuscripten_US
kusw.oapolicyThis item meets KU Open Access policy criteria.en_US
dc.rights.accessrightsopenAccess


Files in this item

Thumbnail

This item appears in the following Collection(s)

Show simple item record